Parexel and Korea Drug Development Fund collaborate

Published: 19-Jul-2012
Research & Development Pharmaceutical

To accelerate global drug development and commercialisation in Korea


Parexel has become the first contract research organisation to provide services to the Korea Drug Development Fund (KDDF) to help Korean companies develop and commercialise healthcare products for the global market.

The Korean Ministry of Knowledge Economy, the Ministry of Education, Science and Technology, and the Ministry of Health and Welfare set up the KDDF in September 2011 with assets of $1bn with the aim of developing at least 10 new drugs by 2019 for the global market.

Parexel will provide a range of drug development support services for selected investments. The pact follows on from a research agreement signed between Parexel and the ASAN Medical Centre (AMC), in Seoul, South Korea earlier this year.

Dong Ho Lee, ceo of KDDF, said: ‘The Korea Drug Development Fund is pleased to work with Parexel to establish various collaborative channels providing essential resources to Korean academic and research institutions and biopharmaceutical companies.

‘Together with Parexel, KDDF will be able to provide professional consulting services to the Korean research communities to advance research activities and promote important innovation.’

  • Companies:
  • Parexel International
See more

You may also like

Regulatory

Innovation in clinical trials

Read more
Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change

Trending Articles

  1. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
  2. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
  3. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation
  4. Efficient PFAS-free degassing of aqueous solutions New silicone-based degassing chamber eliminates the risk of PFAS contamination
  5. Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Regulatory

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change
Regulatory

Parexel and EMC to provide cloud-based document and regulatory information management services

Parexel enhances Regulatory Cloud and leverages EMC Documentum for Life Sciences software to offer regulatory solution
Research & Development

Parexel expands clinical trial supply and logistics services

Opens a European coordination hub and distribution centre in Berlin, Germany
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Incorporating CMOs into the clinical trial supply chain

The clinical supply chain involves working with several outsourced partners. Jens Mattuschka, Vice President, CLS Worldwide Operations, Parexel International, looks at core planning to reduce the risk of failure
Regulatory

Parexel acquires ClinIntel

Extending its clinical randomisation and trial supply management services
Research & Development

Parexel acquires Atlas Medical Services

A provider of clinical research services in Turkey
Research & Development

UCB and Parexel sign clinical services agreement

To drive innovation and accelerate development
Subscribe now